Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative. Terconazole was initially approved by the FDA in 1987. This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinical trials.Due to the existence of 2 stereocentres, there are 4 possible stereoisomers for terconazole. Its therapeutic use is listed as antifungals and dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Panlomyc, Triaconazole, Fungistat and Terazol. Its PubChem CID is 441383.
Terconazole
| CAS No | 67915-31-5 |
|---|---|
| Molecular Formula | C26H31Cl2N5O3 |
| Molecular Weight | 532.5 g/mol |
| Synonyms | 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a triazole ketal derivative.
The listed CAS number is 67915-31-5.
The listed molecular formula is C26H31Cl2N5O3.
The listed molecular weight is 532.5 g/mol.
1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine.
The source lists Panlomyc, Triaconazole, Fungistat and Terazol.